Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases

Current Molecular Medicine

Volumn 11, Issue 8, 2011, Pages 696-707

  Deretzi, G ^a   Kountouras, J ^b   Polyzos, S A ^b   Zavos, C ^b   Giartza Taxidou, E ^b   Gavalas, E ^b   Tsiptsios, I ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Central nervous system; Dysbiosis; Gastrointestinal immune system; Helicobacter pylori; Neurodegeneration; Neuroinflammation

Indexed keywords

BACTERIAL DNA; CHYMASE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 8; NEUROTRANSMITTER; REACTIVE OXYGEN METABOLITE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP2; TRYPTASE; VASCULOTROPIN;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; BLOOD BRAIN BARRIER; CAMPYLOBACTER JEJUNI; CD8+ T LYMPHOCYTE; DEGENERATIVE DISEASE; DENDRITIC CELL; DIGESTIVE SYSTEM INFLAMMATION; DISEASE COURSE; EPILEPSY; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE FLORA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; REVIEW; TH1 CELL;

ANTI-INFLAMMATORY AGENTS; BRAIN; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; NEUROIMMUNOMODULATION;

HELICOBACTER PYLORI;

EID: 80053946733     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652411797536660     Document Type: Review

References (121)

1. Agrawal SM, Yong VW. The many faces of EMMPRIN - roles in neuroinflammation. Biochim Biophys Acta 2011; 1812: 213-9.
2. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918-34.
3. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovère C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 2010; 224: 93-100.
4. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009; 8: 205-16.
5. Town T, Nikolic V, Tan J. The microglial activation continuum: from innate to adaptive responses. J Neuroinflammation 2005; 2: 24.
6. Hensley K. Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 2010; 21: 1-14.
7. Kountouras J, Gavalas E, Zavos C, et al. Alzheimer's disease and Helicobacter pylori infection: Defective immune regulation and apoptosis as proposed common links. Med Hypotheses 2007; 68: 378-88.
8. Kountouras J, Tsolaki M, Gavalas E, et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006; 66: 938-40.
9. Pfeiffer RF. Neuroinflammation and Parkinson disease: the silent battleground. Neurology 2009; 73: 1434-5.
10. Gavalas E, Kountouras J, Deretzi G, et al. Helicobacter pylori and multiple sclerosis. J Neuroimmunol 2007; 188: 187-9.
11. Fabene PF, Bramanti P, Constantin G. The emerging role for chemokines in epilepsy. J Neuroimmunol 2010; 224: 22-7.
12. Schwartz M, Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol 2010; 6: 405-10.
13. Serres S, Anthony DC, Jiang Y, et al. Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neurosci 2009; 29: 4820-8.
14. Giovannoni G, Cutter GR, Lunemann J, et al. Infectious causes of multiple sclerosis. Lancet Neurol 2006; 5: 887-94.
15. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 2003; 136: 1-8.
16. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV. An updated meta analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010; 5: e12496.
17. Ascherio A, Munger KL. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol 2010; 160: 120-4.
18. Kountouras J, Gavalas E, Deretzi G, et al. Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult Scler 2010; 16: 376-7.
19. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 2009; 5: 348-60.
20. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 2004; 25: 619-27.
21. Dobbs RJ, Dobbs SM, Weller C, et al. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 2008; 13: 309-22.
22. Dobbs SM, Dobbs RJ, Weller C, et al. Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism. Helicobacter 2010; 15: 279-94.
23. Kountouras J, Boziki M, Gavalas E, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J Neurol 2009; 256: 758-67.
24. Kountouras J, Boziki M, Gavalas E, et al. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 2010; 23: 199-204.
25. Deretzi G, Kountouras J, Grigoriadis N, et al. From the little brain gastrointestinal infection to the big brain neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis. Med Hypotheses 2009; 73: 781-7.
26. Bienenstock J, Collins S. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms. Clin Exp Immunol 2010; 160: 85-91.
27. Niess JH, Reinecker HC. Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract. Curr Opin Gastroenterol 2005; 21: 687-91.
28. Niess JH. Role of gut-resident dendritic cells in inflammatory bowel disease. Expert Rev Clin Immunol 2009; 5: 451-61.
29. Lapaquette P, Darfeuille-Michaud A. Abnormalities in the handling of intracellular bacteria in Crohn's disease. J Clin Gastroenterol 2010; 44 Suppl 1: S26-9.
30. Huett A, Xavier RJ. Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16: 152-74.
31. Yuan Q, Walker WA. Innate immunity of the gut: mucosal defense in health and disease. J Pediatr Gastroenterol Nutr 2004; 38: 463-73.
32. Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat Res 2007; 622: 70-83.
33. Newkirk MM, Zbar A, Baron M, Manges AR. Distinct bacterial colonization patterns of Escherichia coli subtypes associate with rheumatoid factor status in early inflammatory arthritis. Rheumatology (Oxford) 2010; 49: 1311-6.
34. Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health. Curr Drug Metab 2009; 10: 68-78.
35. De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 2010; 10: 63.
36. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002; 3: 715-20.
37. Doré J, Corthier G. Le microbiote intestinal humain. Gastroenterol Clin Biol 2010; 34 Suppl 1: S7-15.
38. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun 2010; 24: 9-16.
39. Neufeld KA, Foster JA. Effects of gut microbiota on the brain: implications for psychiatry. J Psychiatry Neurosci 2009; 34: 230-1.
40. Bercik P, Verdu EF, Foster JA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139: 2102-12.e1.
41. Wei B, Wingender G, Fujiwara D, et al. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J Immunol 2010; 184: 1218-26.
42. Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 2008; 173: 1714-23.
43. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011; 108 Suppl 1: 4615-22.
44. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009; 183: 6041-50.
45. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136: 2003-14.
46. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 2004; 10: RA55-62.
47. Taché Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004; 16 Suppl 1: 137-42.
48. Caso JR, Leza JC, Menchén L. The effects of physical and psychological stress on the gastro-intestinal tract: lessons from animal models. Curr Mol Med 2008; 8: 299-312.
49. Hart A, Kamm MA. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 2002; 16: 2017-28.
50. Aszalós Z. Neurological and psychiatric aspects of some gastrointestinal diseases. Orv Hetil 2008; 149: 2079-86.
51. Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 2010; 161: 19-27.
52. O'Mahony SM, Bulmer DC, Coelho AM, et al. 5-HT(2B) receptors modulate visceral hypersensitivity in a stresssensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil 2010; 22: 573-8, e124.
53. Bar-Or A. The immunology of multiple sclerosis. Semin Neurol 2008; 28: 29-45.
54. Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B. The idiotype connection: linking infection and multiple sclerosis. Trends Immunol 2010; 31: 56-62.
55. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002; 25: 154-9.
56. Perry VH. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 2010; 120: 277-86.
57. Diomedi M, Stanzione P, Sallustio F, et al. Cytotoxinassociated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 2008; 13: 525-31.
58. Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008; 6: 625-34.
59. Keep RF, Xiang J, Ennis SR, et al. Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir Suppl 2008; 105: 73-7.
60. Westall FC. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 2006; 44: 2099-104.
61. Bennett J, Basivireddy J, Kollar A, et al. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol 2010; 229: 180-91.
62. Jäger A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 2010; 72: 173-84.
63. Kountouras J. Helicobacter pylori: an intruder involved in conspiring glaucomatous neuropathy. Br J Ophthalmol 2009; 93: 1413-5.
64. Guerreiro RJ, Santana I, Brás JM, Santiago B, Paiva A, Oliveira C. Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener Dis 2007; 4: 406-12.
65. Tan ZS, Beiser AS, Vasan RS, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 2007; 68: 1902-8.
66. Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res 2008; 146: 149-58.
67. Kountouras J, Tsolaki M, Boziki M, et al. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol 2007; 14: 976-82.
68. Kountouras J, Boziki M, Gavalas E, et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci 2009; 119: 765-77.
69. Charlett A, Dobbs RJ, Dobbs SM, et al. Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease. Gut Pathog 2009; 1: 20.
70. Supajatura V, Ushio H, Wada A, et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002; 168: 2603-7.
71. Kountouras J, Zavos C, Diamantidis MD, et al. A concept of Helicobacterpylori and stress-secreted mast cells' potential involvement in brain metastases. J Neuroimmunol 2009; 209: 121-2.
72. Theoharides TC, Rozniecki JJ, Sahagian G, et al. Impact of stress and mast cells on brain metastases. J Neuroimmunol 2008; 205: 1-7.
73. Terebiznik MR, Raju D, Vázquez CL, et al. Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 2009; 5: 370-9.
74. Raju D, Jones NL. Methods to monitor autophagy in H. pylori vacuolating cytotoxin A (VacA)-treated cells. Autophagy 2010; 6: 138-43.
75. Wang YH, Wu JJ, Lei HY. When Helicobacter pylori invades and replicates in the cells. Autophagy 2009; 5: 540-2.
76. Pytko-Polonczyk J, Konturek SJ, Karczewska E, Bielański W, Kaczmarczyk-Stachowska A. Oral cavity as permanent reservoir of Helicobacter pylori and potential source of reinfection. J Physiol Pharmacol 1996; 47: 121-9.
77. Saccà SC, Pascotto A, Venturino GM, et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci 2006; 47: 501-8.
78. Li W, Minohara M, Piao H, et al. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2009; 15: 1411-21.
79. Sfriso P, Ghirardello A, Botsios C, et al. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2010; 87: 385-95.
80. Kountouras J, Deretzi G, Zavos C, et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2005; 12: 139-43.
81. Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun 2001; 16: 241-56.
82. Kountouras J, Deretzi G, Grigoriadis N, et al. Guillain-Barré syndrome. Lancet Neurol 2008; 7: 1080-1.
83. Kountouras J, Mylopoulos N, Konstas AG, Zavos C, Chatzopoulos D, Boukla A. Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 2003; 241: 884-90.
84. Kountouras J, Zavos C, Deretzi G. Primary open-angle glaucoma. N Engl J Med 2009; 360: 2679.
85. Metchnikoff E. The Prolongation of Life: Optimistic Studies. London: William Heinemann 1907; pp. 161-83.
86. Kelly P. Nutrition, intestinal defence and the microbiome. Proc Nutr Soc 2010; 69: 261-8.
87. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-85.
88. Stanghellini V, Barbara G, Cremon C, et al. Gut microbiota and related diseases: clinical features. Intern Emerg Med 2010; 5 Suppl 1: S57-63.
89. Tezuka H, Ohteki T. Regulation of intestinal homeostasis by dendritic cells. Immunol Rev 2010; 234: 247-58.
90. Nagatani K, Komagata Y, Asako K, Takayama M, Yamamoto K. Antigen-specific regulatory T cells are detected in Peyer's patches after the interaction between T cells and dendritic cells loaded with orally administered antigen. Immunobiology 2011; 216: 416-22.
91. Singh V, Singh K, Amdekar S, et al. Innate and specific gut associated immunity and microbial interference. FEMS Immunol Med Microbiol 2009; 55: 6-12.
92. Garside P, Millington O, Smith KM. The anatomy of mucosal immune responses. Ann N Y Acad Sci 2004; 1029: 9-15.
93. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15: 100-13.
94. Pabst O, Bernhardt G. The puzzle of intestinal lamina propria dendritic cells and macrophages. Eur J Immunol 2010; 40: 2107-11.
95. Vulcano M, Danese S, Sica A. Tolerance in intestinal inflammation and cancer. Curr Drug Targets 2008; 9: 404-12.
96. Garside P, Mowat AM. Oral tolerance. Semin Immunol 2001; 13: 177-85.
97. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 2007; 19: 70-83.
98. Underwood MA, Bevins CL. Defensin-barbed innate immunity: clinical associations in the pediatric population. Pediatrics 2010; 125: 1237-47.
99. Lelouard H, Henri S, De Bovis B, et al. Pathogenic bacteria and dead cells are internalized by a unique subset of Peyer's patch dendritic cells that express lysozyme. Gastroenterology 2010; 138: 173-84.e1-3.
100. Ouellette AJ. Paneth cells and innate mucosal immunity. Curr Opin Gastroenterol 2010; 26: 547-53.
101. Eberl G, Sawa S. Opening the crypt: current facts and hypotheses on the function of cryptopatches. Trends Immunol 2010; 31: 50-5.
102. Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, Qin H. IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol 2010; 184: 4898-906.
103. Gustafsson BE, Laurell CB. G Gamma globulins in germ-free rats. J Exp Med 1958; 108: 251-8.
104. Tlaskalová-Hogenová H, Tucková L, Stepánková R, et al. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann N Y Acad Sci 2005; 1051: 787-98.
105. Tlaskalová-Hogenová H, Stepánková R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004; 93: 97-108.
106. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-18.
107. Gareau MG, Wine E, Rodrigues DM, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60: 307-17.
108. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-64, e119.
109. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558(Pt 1): 263-75.
110. Fox A, Fox K. Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits. Infect Immun 1991; 59: 1202-5.
111. Fox A, Fox K, Christensson B, Harrelson D, Krahmer M. Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids. Infect Immun 1996; 64: 3911-5.
112. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10: 735-44.
113. Felts PA, Woolston AM, Fernando HB, et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 2005; 128(Pt 7): 1649-66.
114. Qin H, Wilson CA, Lee SJ, Zhao X, Benveniste EN. LPS induces CD40 gene expression through the activation of NFkappaB and STAT-1alpha in macrophages and microglia. Blood 2005; 106: 3114-22.
115. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory Tcell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107: 12204-9.
116. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005; 54: 317-20.
117. Rook GA, Martinelli R, Brunet LR. Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr Opin Allergy Clin Immunol 2003; 3: 337-42.
118. del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Förster R. Development and functional specialization of CD103+ dendritic cells. Immunol Rev 2010; 234: 268-81.
119. Edström M, Mellergård J, Mjösberg J, et al. Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood. Mult Scler 2011; 17: 57-66.
120. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010; 185: 4101-8.
121. Lavasani S, Dzhambazov B, Nouri M, et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010; 5: e9009.